Pub­li­ca­tions

The gut micro­bio­me enhances anti-PD‑1 effi­ca­cy in a tumor-agnos­tic man­ner: results from a phase II tri­al of fecal micro­bio­ta trans­plan­ta­tion and anti-PD‑1 re-induc­tion in MSI‑H refrac­to­ry cancers